Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Loos

Showing results (101-110 of 215) with videos related to

Pageof 22
Sort By:
Anti-Cancer Drugs|March 14, 2003
Red blood cells: a neglected compartment in topotecan pharmacokinetic analysisWalter J Loos, Hans Gelderblom, Jaap Verweij, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2013
The issue of non-specific binding of cabazitaxelPeter de Bruijn, Inge M Ghobadi Moghaddam-Helmantel, Walter J Loos, et al.
British Journal of Cancer|July 4, 1998
Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell lineJ Ma, M Maliepaard, K Nooter, et al.
Anti-Cancer Drugs|November 26, 1999
Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humansW J Loos, J Verweij, H J Gelderblom, et al.
Clinical Pharmacology and Therapeutics|October 31, 2003
Disposition of polyoxyethylated excipients in humans: implications for drug safety and formulation approachesAlbert J Ten Tije, Walter J Loos, Jaap Verweij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Pharmacokinetics and bioavailability of oral 9-aminocamptothecin capsules in adult patients with solid tumorsA Sparreboom, M J de Jonge, C J Punt, et al.
Cancer Biology & Therapy|May 24, 2005
Effect of ABCG2 genotype on the oral bioavailability of topotecanAlex Sparreboom, Walter J Loos, Herman Burger, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2008
Application of prolonged microdialysis sampling in carboplatin-treated cancer patientsInge R H M Konings, Frederike K Engels, Stefan Sleijfer, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 26, 2009
Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometryPeter de Bruijn, Stefan Sleijfer, Mei-Ho Lam, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
Mechanism-based models for topotecan-induced neutropeniaFrédéric Léger, Walter J Loos, Roland Bugat, et al.
Pageof 22

Showing results (101-110 of 215) with videos related to

Sort By:
Pageof 22
Anti-Cancer Drugs|March 14, 2003
Red blood cells: a neglected compartment in topotecan pharmacokinetic analysisWalter J Loos, Hans Gelderblom, Jaap Verweij, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2013
The issue of non-specific binding of cabazitaxelPeter de Bruijn, Inge M Ghobadi Moghaddam-Helmantel, Walter J Loos, et al.
British Journal of Cancer|July 4, 1998
Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell lineJ Ma, M Maliepaard, K Nooter, et al.
Anti-Cancer Drugs|November 26, 1999
Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humansW J Loos, J Verweij, H J Gelderblom, et al.
Clinical Pharmacology and Therapeutics|October 31, 2003
Disposition of polyoxyethylated excipients in humans: implications for drug safety and formulation approachesAlbert J Ten Tije, Walter J Loos, Jaap Verweij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Pharmacokinetics and bioavailability of oral 9-aminocamptothecin capsules in adult patients with solid tumorsA Sparreboom, M J de Jonge, C J Punt, et al.
Cancer Biology & Therapy|May 24, 2005
Effect of ABCG2 genotype on the oral bioavailability of topotecanAlex Sparreboom, Walter J Loos, Herman Burger, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2008
Application of prolonged microdialysis sampling in carboplatin-treated cancer patientsInge R H M Konings, Frederike K Engels, Stefan Sleijfer, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 26, 2009
Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometryPeter de Bruijn, Stefan Sleijfer, Mei-Ho Lam, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
Mechanism-based models for topotecan-induced neutropeniaFrédéric Léger, Walter J Loos, Roland Bugat, et al.
Pageof 22